Sort
21,453 grants matching “tuberculosis”
M.tuberculosis Rpfs: Modulators of Reactivation
$241,779Joann M Tufariello · Albert Einstein College Of Medicine · R21 · FY2007 · AI
Nanoluciferase reporter phage for rapid phenotypic characterization of resistance to next-generation antimycobacterial agents
$241,715Max O'Donnell · Columbia University Health Sciences · R21 · FY2023 · AI
VU-Mozambique Collaborative Research Ethics Education Program
$241,698D. Troy Moon · Vanderbilt University · R25 · FY2015 · TW
TB Alliance CETR Administrative Core
$241,677Nader Fotouhi · Global Alliance For Tb Drug Development · U19 · FY2019 · AI
Structural Biology of Protein Complexes of Mtb
$241,546David S Eisenberg · Texas A&M University · P01 · FY2013 · AI
Macaque T cell signatures of Mtb control
$241,509Jyothi Rengarajan · Emory University · U19 · FY2019 · AI
BACTERIAL AND LIPOSOMAL ANTIGEN PROCESSING
$241,501Case Western Reserve University · R01 · FY2000 · AI
GAIT complex formation and Mycobacterium tuberculosis
$241,500Liem Duy Nguyen · Case Western Reserve University · R21 · FY2021 · AI
Multiplexed point-of-care molecular detection for multiple infections in co-endemic settings
$241,500Robert M Greenberg · University Of Pennsylvania · R21 · FY2017 · AI
Impact of Pregnancy on Tuberculosis
$241,484Jerrold J. Ellner · Boston Medical Center · R01 · FY2018 · AI
Vanderbilt Infection Pathogenesis and Epidemiology Research Training Program
$241,426Spyros A Kalams · Vanderbilt University · T32 · FY2014 · AI
Regulation of antibiotic tolerance in Mycobacterium abscessus by proteolytic signaling
$241,375Bennett Penn · University Of California At Davis · R21 · FY2024 · AI
Noncompetitive inhibition of CYP121 dimers from Mycobacterium tuberculosis
$241,375David Fernando Estrada · State University Of New York At Buffalo · R21 · FY2024 · AI
PROGRESSIVE IMPAIRMENT OF LUNG IMMUNITY IN HIV INFECTION
$241,330Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2000 · HL
The Role of Group 3 Innate Lymphoid cells (ILC3) in Tuberculosis
$241,329Shabaana A. Khader · Washington University · R01 · FY2021 · AI
Tuberculosis Elimination and Laboratory Program Funding. The Rhode Island Tubercu
$241,295Utpala Bandy · Rhode Island State Dept Of Health · U52 · FY2014 · PS
Mali International Center for Excellence in Research: Filariasis
$241,289Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Analysis of Host-Pathogen Interactions
$241,185Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Optimization and mechanistic studies of halogenated phenazines and quinolines as anti-tuberculosis therapeutics
$241,150Kyle H Rohde · University Of Central Florida · R21 · FY2021 · AI
Crystalline Endolysin Treatment for Tuberculosis in TB/HIV co-infected patients
$241,150Bhami Shenoy · Procrysta Biologix, Inc. · R43 · FY2011 · AI
Long-term Effects of Early-Life Arsenic Exposure on Immunity
$241,096Fenna Sille · Johns Hopkins University · R00 · FY2019 · ES
Mopati: A Pilot HIV Treatment Partner Intervention in Botswana
$241,074Laura M Bogart · Rand Corporation · R34 · FY2021 · MH
Reduced Injectable, Short-course for (E)Xpert MDR-TB [RISE trial]
$241,000Scott K Heysell · University Of Virginia · R34 · FY2014 · AI
A Novel Clock to Monitor M. tuberculosis in vivo
$241,000David R Sherman · Seattle Biomedical Research Institute · R21 · FY2010 · HL
Novel strategies for treatment of Mycobacterium abscessus pulmonary disease
$240,878Susan E Dorman · Medical University Of South Carolina · R34 · FY2025 · AI